Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Boehringer Ingelheim Vetmedica Inc
Boehringer Ingelheim Vetmedica Inc_20100107

Boehringer Ingelheim Vetmedica Inc patents


Recent patent applications related to Boehringer Ingelheim Vetmedica Inc. Boehringer Ingelheim Vetmedica Inc is listed as an Agent/Assignee. Note: Boehringer Ingelheim Vetmedica Inc may have other listings under different names/spellings. We're not affiliated with Boehringer Ingelheim Vetmedica Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Boehringer Ingelheim Vetmedica Inc-related inventors


Quantification of vaccine compositions

The invention provides methods and mass-labeled peptides for use in said methods for quantifying the presence of a one or more viral proteins in a sample of a preparation containing agents which bind to said viral protein, using mass-spectroscopic analyses of the sample and standards containing known amounts of labeled... Boehringer Ingelheim Vetmedica Inc

Porcine circovirus type 2 (pcv2) subunit vaccine

Vaccination methods to control PCV2 infection with different PCV2 subtypes are disclosed. Specifically, a PCV2 subtype b (PCV2b) ORF2 proteins or immunogenic compositions comprising a PCV2b ORF2 protein are used in a method for the treatment or prevention of an infection with PCV2 of a different subtype, the reduction, prevention... Boehringer Ingelheim Vetmedica Inc

Liquid preparation comprising pimobendan

A liquid preparation includes an etherified cyclodextrin derivative and a substituted benzimidazol, where the etherified cyclodextrin derivative is one of alpha-, beta, and gamma-cyclodextrin ether.... Boehringer Ingelheim Vetmedica Inc

Prevention and treatment of sub-clinical pcvd

The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.... Boehringer Ingelheim Vetmedica Inc

Salmonella choleraesuis-salmonella typhimurium vaccines

The present invention relates methods of reducing fecal shedding of animals infected with Salmonella by use of a vaccine or immunogenic composition of Salmonella Choleraesuis-Typhimurium.... Boehringer Ingelheim Vetmedica Inc

Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs

The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 2 (PCV2) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV2 infection. Preferably, they include lymphadenopathy, lymphoid depletion and/or multinucleated/giant histiocytes. Moreover, the clinical symptoms... Boehringer Ingelheim Vetmedica Inc

Treatment of pigs with pcv2 antigen

The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the... Boehringer Ingelheim Vetmedica Inc

West nile virus vaccine

The invention provides for immunogenic compositions against West Nile Virus. The immunogenic compositions, in alternate embodiments, also include other equine pathogens. The West Nile Virus composition of the present invention advantageously provides for protection against North American Dominant West Nile Virus strains or isolates.... Boehringer Ingelheim Vetmedica Inc

Treatment of prdc in pigs

The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.... Boehringer Ingelheim Vetmedica Inc

Pcv2 orf2 protein variant and virus like particles composed thereof

Vaccination methods to control PCV2 infection with different PCV2 subtypes are disclosed. Specifically, a PCV2 subtype b (PCV2b) ORF2 proteins or immunogenic compositions comprising a PCV2b ORF2 protein are used in a method for the treatment or prevention of an infection with PCV2 of the same PCV2b and/or different subtype;... Boehringer Ingelheim Vetmedica Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Boehringer Ingelheim Vetmedica Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Boehringer Ingelheim Vetmedica Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###